Article Text

Download PDFPDF
CASE REPORT
Metachronous solitary plasmacytoma
  1. Robin Khosa1,
  2. Shishir Seth2,
  3. Sapna Nangia1
  1. 1Radiation Oncology, Apollo Cancer Institute, Indraprastha Apollo Hospital, New Delhi, Delhi, India
  2. 2Apollo Cancer Institute, Indraprastha Apollo Hospital, New Delhi, Delhi, India
  1. Correspondence to Dr Sapna Nangia, sapna_nangia{at}outlook.com, nangia.sapna{at}gmail.com

Summary

Solitary plasmacytoma is a rare disorder comprising 5%–10% of all plasma cell neoplasms. Progression to multiple myeloma is the most common pattern of relapse. Appearance of new lesions without any systemic disease is the most unusual pattern of relapse seen in <2% cases. We present a case of a 46-year-old female who presented with features of third and seventh cranial nerve palsy, diagnosed with solitary plasmacytoma, with no evidence of any systemic disease. As per standard recommendations, the patient received radiotherapy to the local site. The patient developed relapse twice, at three sites, during the follow-up period. Investigations revealed no evidence of any systemic disease. In view of repeat relapses, the patient was started on immune modulatory agent. Two and half years after the last radiotherapy, the patient is symptom free with no evidence of any new lesion.

  • oncology
  • radiotherapy
  • haematology (incl blood transfusion)

Statistics from Altmetric.com

Footnotes

  • Contributors First author, RK, has been involved in collection and interpretation of data, and writing the manuscript. Second and third authors, SS and SN, have been involved in patient care, including design and delivery of treatment. SN has reviewed and revised the manuscript. All the three authors are involved in follow-up care of the patient.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.